<table>
<thead>
<tr>
<th>报告人姓名</th>
<th>关系</th>
<th>类型</th>
<th>金额</th>
<th>SEC 文件</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lee Tien-Li</td>
<td>首席执行官，10% 股东</td>
<td>购买</td>
<td>$101,395</td>
<td>Form 4</td>
</tr>
<tr>
<td>Sun Nelson</td>
<td>首席财务官，10% 股东</td>
<td>购买</td>
<td>$43,200</td>
<td>Form 4</td>
</tr>
</tbody>
</table>
<p>Lee Tien-Li，Aardvark Therapeutics 的首席执行官和 10% 股东，通过以每股 $14.485 的价格购买 7,000 股，扩大了他在公司的股份，总交易金额为 $101,395。此次收购后，Lee Tien-Li 在公司的直接持股总数达到 1,551,613 股，此外还通过配偶间接持有 1,474,028 股。</p>
<p>Sun Nelson，Aardvark Therapeutics 的首席财务官和 10% 股东，也通过以每股 $14.4 的价格购买 3,000 股，增加了他在公司的投资，总金额为 $43,200。这笔交易使 Nelson 的直接持股总数达到 108,484 股。</p>

AARD

<p>Aardvark Therapeutics 的首席执行官李天立和首席财务官孙尼尔森增加了他们在公司的持股。李天立以 101,395 美元购买了 7,000 股，使他的直接持股增至 1,551,613 股，间接持股增至 1,474,028 股。孙尼尔森以 43,200 美元收购了 3,000 股，使他的直接持股增至 108,484 股</p>

<table>
<thead>
<tr>
<th>Reporter Name</th>
<th>Relationship</th>
<th>Type</th>
<th>Amount</th>
<th>SEC Filing</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lee Tien-Li</td>
<td>Chief Executive Officer, 10% Owner</td>
<td>Purchase</td>
<td>$101,395</td>
<td>Form 4</td>
</tr>
<tr>
<td>Sun Nelson</td>
<td>Chief Financial Officer, 10% Owner</td>
<td>Purchase</td>
<td>$43,200</td>
<td>Form 4</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>报告人姓名</th>
<th>关系</th>
<th>类型</th>
<th>金额</th>
<th>SEC 文件</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lee Tien-Li</td>
<td>首席执行官，10% 股东</td>
<td>购买</td>
<td>$101,395</td>
<td>Form 4</td>
</tr>
<tr>
<td>Sun Nelson</td>
<td>首席财务官，10% 股东</td>
<td>购买</td>
<td>$43,200</td>
<td>Form 4</td>
</tr>
</tbody>
</table>
</div><p>Lee Tien-Li, Chief Executive Officer and 10% Owner of Aardvark Therapeutics, has expanded his stake in the company by purchasing 7,000 shares at a price of $14.485 each, resulting in a total transaction value of $101,395. Following this acquisition, Lee Tien-Li's direct ownership in the company amounts to 1,551,613 shares, with an additional 1,474,028 shares held indirectly through a spouse.</p>
<div class="lb-trans"><p>Lee Tien-Li，Aardvark Therapeutics 的首席执行官和 10% 股东，通过以每股 $14.485 的价格购买 7,000 股，扩大了他在公司的股份，总交易金额为 $101,395。此次收购后，Lee Tien-Li 在公司的直接持股总数达到 1,551,613 股，此外还通过配偶间接持有 1,474,028 股。</p>
</div><p>Sun Nelson, Chief Financial Officer and 10% owner of Aardvark Therapeutics, also increased his investment in the company by acquiring 3,000 shares at a price of $14.4 per share, totaling $43,200. This transaction brings Nelson's direct ownership to 108,484 shares.</p>
<div class="lb-trans"><p>Sun Nelson，Aardvark Therapeutics 的首席财务官和 10% 股东，也通过以每股 $14.4 的价格购买 3,000 股，增加了他在公司的投资，总金额为 $43,200。这笔交易使 Nelson 的直接持股总数达到 108,484 股。</p>
</div>

Aardvark Therapeutics 的高管们增加了他们的持股量